Citadel Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
+66,900
New +$1.28M ﹤0.01% 7167
2025
Q4
Sell
-14,900
Closed -$400K 14016
2025
Q3
$400K Sell
14,900
-20,700
-58% -$494K ﹤0.01% 9669
2025
Q2
$597K Sell
35,600
-63,000
-64% -$1.11M ﹤0.01% 8219
2025
Q1
$1.74M Buy
98,600
+32,400
+49% +$650K ﹤0.01% 5803
2024
Q4
$1.61M Sell
66,200
-29,100
-31% -$831K ﹤0.01% 6081
2024
Q3
$3.54M Buy
95,300
+46,700
+96% +$1.74M ﹤0.01% 4506
2024
Q2
$2.31M Buy
48,600
+1,600
+3% +$70.1K ﹤0.01% 5043
2024
Q1
$1.8M Buy
47,000
+26,300
+127% +$855K ﹤0.01% 5729
2023
Q4
$646K Sell
20,700
-33,100
-62% -$1.19M ﹤0.01% 7554
2023
Q3
$2.16M Buy
53,800
+6,700
+14% +$314K ﹤0.01% 5073
2023
Q2
$2.48M Sell
47,100
-10,200
-18% -$621K ﹤0.01% 4790
2023
Q1
$3.66M Buy
57,300
+29,400
+105% +$1.92M ﹤0.01% 4327
2022
Q4
$1.35M Sell
27,900
-64,100
-70% -$4.02M ﹤0.01% 6235
2022
Q3
$6.49M Buy
92,000
+56,300
+158% +$4.82M ﹤0.01% 3446
2022
Q2
$2.53M Sell
35,700
-3,400
-9% -$219K ﹤0.01% 5074
2022
Q1
$3.12M Sell
39,100
-57,800
-60% -$4.3M ﹤0.01% 5081
2021
Q4
$8.85M Sell
96,900
-35,400
-27% -$3.8M ﹤0.01% 3277
2021
Q3
$17M Buy
132,300
+16,000
+14% +$2.24M ﹤0.01% 2240
2021
Q2
$17.7M Buy
116,300
+46,900
+68% +$6.18M ﹤0.01% 2228
2021
Q1
$7.32M Sell
69,400
-16,700
-19% -$1.67M ﹤0.01% 3492
2020
Q4
$6.82M Buy
86,100
+51,500
+149% +$3.77M ﹤0.01% 3162
2020
Q3
$1.96M Sell
34,600
-22,200
-39% -$1.2M ﹤0.01% 4753
2020
Q2
$3.5M Buy
56,800
+40,900
+257% +$1.67M ﹤0.01% 3607
2020
Q1
$513K Buy
15,900
+6,600
+71% +$222K ﹤0.01% 6423
2019
Q4
$327K Sell
9,300
-10,500
-53% -$346K ﹤0.01% 7457
2019
Q3
$510K Buy
19,800
+5,400
+38% +$164K ﹤0.01% 6712
2019
Q2
$423K Buy
14,400
+2,600
+22% +$75.1K ﹤0.01% 7070
2019
Q1
$403K Buy
+11,800
New +$417K ﹤0.01% 7154
2018
Q4
Sell
-14,800
Closed -$710K 9729
2018
Q3
$710K Sell
14,800
-6,500
-31% -$266K ﹤0.01% 6138
2018
Q2
$660K Buy
+21,300
New +$498K ﹤0.01% 5920
2015
Q3
Sell
-1,000
Closed -$10K 9219
2015
Q2
$10K Buy
+1,000
New +$9.27K ﹤0.01% 8406
2015
Q1
Sell
-6,400
Closed -$58K 8833
2014
Q4
$58K Buy
6,400
+400
+7% +$3.87K ﹤0.01% 7085
2014
Q3
$64K Buy
6,000
+1,400
+30% +$16.6K ﹤0.01% 6749
2014
Q2
$77K Buy
+4,600
New +$75.7K ﹤0.01% 6433

Other funds holding STAA

Citadel Advisors's STAA Position: Q1 2026 in Review

Citadel Advisors increased its STAAR Surgical (STAA) stake by 416% in Q1 2026, buying an estimated $16.3M and bringing the position to 1,059,428 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2354.

Citadel Advisors first reported a position in STAA in Q4 2013 and has held it in 39 quarters since. The position peaked at $38M in Q3 2023. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Citadel Advisors held 1,059,428 shares of STAAR Surgical worth $19.8M as of Q1 2026.
  • Citadel Advisors bought 854,309 STAAR Surgical shares in Q1 2026, an estimated $16.3M.
  • STAAR Surgical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2354 holding.
  • Citadel Advisors first reported a position in STAAR Surgical in Q4 2013 and has held it in 39 quarters since.
  • Citadel Advisors's STAAR Surgical position peaked at $38M in Q3 2023.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.